[{"address1": "777 Township Line Road", "address2": "Suite 300", "city": "Yardley", "state": "PA", "zip": "19067", "country": "United States", "phone": "267 364 3500", "fax": "267 395 2119", "website": "https://www.optinose.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists. It offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps, as well as is in Phase III clinical trial for treatment of chronic sinusitis; and Onzetra Xsail, a powder EDS device. The company was founded in 2000 and is headquartered in Yardley, Pennsylvania. As of May 21, 2025, OptiNose, Inc. operates as a subsidiary of Paratek Pharmaceuticals, Inc.", "fullTimeEmployees": 127, "companyOfficers": [], "auditRisk": 5, "boardRisk": 7, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1746057600, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 9.6, "open": 9.69, "dayLow": 9.6, "dayHigh": 9.6, "regularMarketPreviousClose": 9.6, "regularMarketOpen": 9.69, "regularMarketDayLow": 9.6, "regularMarketDayHigh": 9.6, "payoutRatio": 0.0, "beta": -0.885, "forwardPE": -106.666664, "volume": 811056, "regularMarketVolume": 811056, "averageVolume": 127728, "averageVolume10days": 117603, "averageDailyVolume10Day": 117603, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 97223040, "fiftyTwoWeekLow": 4.814999, "fiftyTwoWeekHigh": 20.025, "priceToSalesTrailing12Months": 1.1877326, "fiftyDayAverage": 8.91, "twoHundredDayAverage": 8.828722, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 153887856, "profitMargins": -0.36515, "floatShares": 6304700, "sharesOutstanding": 10127400, "sharesShort": 132651, "sharesShortPriorMonth": 191735, "sharesShortPreviousMonthDate": 1743379200, "dateShortInterest": 1745971200, "sharesPercentSharesOut": 0.013099999, "heldPercentInsiders": 0.063379996, "heldPercentInstitutions": 0.72369003, "shortRatio": 1.38, "shortPercentOfFloat": 0.0150999995, "impliedSharesOutstanding": 10127400, "bookValue": -6.059, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -29890000, "trailingEps": -2.17, "forwardEps": -0.09, "lastSplitFactor": "1:15", "lastSplitDate": 1735603200, "enterpriseToRevenue": 1.88, "enterpriseToEbitda": -9.884, "52WeekChange": -0.45299143, "SandP52WeekChange": 0.13161862, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "OPTN", "underlyingSymbol": "OPTN", "shortName": "OptiNose, Inc.", "longName": "OptiNose, Inc.", "firstTradeDateEpochUtc": 1507901400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "9935cfef-8b2d-350a-a595-96d5fb99e4f0", "messageBoardId": "finmb_252053415", "gmtOffSetMilliseconds": -14400000, "currentPrice": 9.6, "targetHighPrice": 44.99998, "targetLowPrice": 9.0, "targetMeanPrice": 20.99999, "targetMedianPrice": 9.0, "recommendationMean": 2.33333, "recommendationKey": "buy", "numberOfAnalystOpinions": 3, "totalCash": 72933000, "totalCashPerShare": 7.202, "ebitda": -15570000, "totalDebt": 129598000, "quickRatio": 0.549, "currentRatio": 0.64, "totalRevenue": 81856000, "revenuePerShare": 7.314, "returnOnAssets": -0.09968001, "grossProfits": 74106000, "freeCashflow": -8373875, "operatingCashflow": -34207000, "revenueGrowth": 0.244, "grossMargins": 0.90532, "ebitdaMargins": -0.19021, "operatingMargins": -0.41005, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2025-07-19"}]